{"id":"https://openalex.org/W2161664513","doi":"https://doi.org/10.2174/138945011794182719","title":"Combined Treatment Modalities for Age Related Macular Degeneration","display_name":"Combined Treatment Modalities for Age Related Macular Degeneration","publication_year":2011,"publication_date":"2011-01-08","ids":{"openalex":"https://openalex.org/W2161664513","doi":"https://doi.org/10.2174/138945011794182719","mag":"2161664513","pmid":"https://pubmed.ncbi.nlm.nih.gov/20887244"},"language":"en","primary_location":{"id":"doi:10.2174/138945011794182719","doi":"https://doi.org/10.2174/138945011794182719","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138945011794182719","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069394627","display_name":"Ronald A. Das","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]},{"id":"https://openalex.org/I4210132687","display_name":"Hospital Selayang","ror":"https://ror.org/03p43tq86","country_code":"MY","type":"healthcare","lineage":["https://openalex.org/I4210132687"]}],"countries":["IT","MY"],"is_corresponding":true,"raw_author_name":"R. A. Das","raw_affiliation_strings":["Selayang Eye Department, Hospital Selayang Batu Caves, Selangor, Malaysia","Eye Clinic, Second University of Naples, via S. Pansini, 5 - 80131 - Naples, Italy.,Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Selayang Eye Department, Hospital Selayang Batu Caves, Selangor, Malaysia","institution_ids":["https://openalex.org/I4210132687"]},{"raw_affiliation_string":"Eye Clinic, Second University of Naples, via S. Pansini, 5 - 80131 - Naples, Italy.,Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Romano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Romano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074600789","display_name":"Flavia Chiosi","orcid":"https://orcid.org/0000-0002-1728-6098","observed_orcids":["https://orcid.org/0000-0002-1728-6098"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Chiosi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045625180","display_name":"Massimo Menzione","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"M. Menzione","raw_affiliation_strings":["Eye Clinic, Second University of Naples, via S. Pansini, 5 - 80131 - Naples, Italy.,Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eye Clinic, Second University of Naples, via S. Pansini, 5 - 80131 - Naples, Italy.,Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101577407","display_name":"Michele Rinaldi","orcid":"https://orcid.org/0000-0003-1823-1686","observed_orcids":["https://orcid.org/0000-0003-1823-1686"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"M. Rinaldi","raw_affiliation_strings":["Eye Clinic, Second University of Naples, via S. Pansini, 5 - 80131 - Naples, Italy.,Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eye Clinic, Second University of Naples, via S. Pansini, 5 - 80131 - Naples, Italy.,Italy","institution_ids":["https://openalex.org/I197809005"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5045625180","https://openalex.org/A5069394627","https://openalex.org/A5101577407"],"corresponding_institution_ids":["https://openalex.org/I197809005","https://openalex.org/I4210132687"],"apc_list":null,"apc_paid":null,"fwci":1.449,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.79721862,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"12","issue":"2","first_page":"182","last_page":"189"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/age-related-macular-degeneration","display_name":"age-related macular degeneration","score":0.9810000061988831},{"id":"https://openalex.org/keywords/neovascular-amd","display_name":"neovascular AMD","score":0.9449999928474426},{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.9100000262260437},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9620000123977661},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/verteporfin-photodynamic-therapy","display_name":"verteporfin photodynamic therapy","score":0.8579999804496765},{"id":"https://openalex.org/keywords/occlusion-therapy","display_name":"occlusion therapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.8930000066757202},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7820000052452087},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.7519999742507935},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.8669999837875366},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pegaptanib","display_name":"pegaptanib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/marina-trial","display_name":"MARINA trial","score":0.6110000014305115},{"id":"https://openalex.org/keywords/anchor-trial","display_name":"ANCHOR trial","score":0.9779999852180481}],"concepts":[{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.9422890543937683},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9157403707504272},{"id":"https://openalex.org/C2781148688","wikidata":"https://www.wikidata.org/wiki/Q782318","display_name":"Verteporfin","level":4,"score":0.8837453722953796},{"id":"https://openalex.org/C2781323092","wikidata":"https://www.wikidata.org/wiki/Q1428072","display_name":"Photodynamic therapy","level":2,"score":0.637994110584259},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.573218822479248},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5146516561508179},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4822257459163666},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4396211802959442},{"id":"https://openalex.org/C2780496003","wikidata":"https://www.wikidata.org/wiki/Q28529682","display_name":"Citicoline","level":2,"score":0.4290660619735718},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.4205496311187744},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3684878349304199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34657561779022217},{"id":"https://openalex.org/C2781359195","wikidata":"https://www.wikidata.org/wiki/Q5105209","display_name":"Choroidal neovascularization","level":3,"score":0.3151031732559204},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1430266797542572},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12690895795822144},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077362","descriptor_name":"Verteporfin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001766","descriptor_name":"Blindness","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D001766","descriptor_name":"Blindness","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D010778","descriptor_name":"Photochemotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011166","descriptor_name":"Porphyrins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011166","descriptor_name":"Porphyrins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017319","descriptor_name":"Photosensitizing Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017319","descriptor_name":"Photosensitizing Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D042442","descriptor_name":"Vascular Endothelial Growth Factors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2174/138945011794182719","doi":"https://doi.org/10.2174/138945011794182719","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138945011794182719","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},{"id":"pmid:20887244","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20887244","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug targets","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unicampania.it:11591/191451","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11591/191451","pdf_url":null,"source":{"id":"https://openalex.org/S7407055255","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi della Campania \"Luigi Vanvitelli\"","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2103190662","https://openalex.org/W2034411501","https://openalex.org/W2046519108","https://openalex.org/W1974254805","https://openalex.org/W2158444687","https://openalex.org/W1963683893","https://openalex.org/W2130822994","https://openalex.org/W2017069086","https://openalex.org/W2027731601","https://openalex.org/W7098841458"],"abstract_inverted_index":{"Background:":[0],"Age-related":[1],"macular":[2,316],"degeneration":[3,317],"(AMD)":[4],"is":[5,235,262,280,293],"a":[6,116,139,199,232,266,274,281,294],"condition":[7],"that":[8,303],"accounts":[9],"for":[10,55,70],"75%":[11],"of":[12,14,22,27,37,45,73,85,96,108,141,148,180,195,202,231,246,272,287,300],"cases":[13],"legal":[15],"blindness":[16],"in":[17,42,93,115,119,122,212],"individuals":[18],"over":[19],"the":[20,34,43,71,90,94,149,153,177,189,192,203,213,229,238,247],"age":[21,314],"50.":[23],"Objectives:":[24],"The":[25,83,127],"objective":[26],"this":[28],"review":[29,65],"has":[30],"been":[31],"to":[32,163,236,277,297,305],"evaluate":[33],"clinical":[35,193,218],"effectiveness":[36],"available":[38],"combined":[39,332],"treatments":[40,251],"modalities":[41],"treatment":[44,102],"neovascular":[46,74,97,125],"AMD.":[47,75,126],"Data":[48],"Sources:":[49],"Central":[50],"and":[51,64,145,175,186,222,243],"Medline":[52],"were":[53],"searched":[54],"original":[56],"research":[57],"studies":[58],"(Phase":[59],"I,":[60],"II,":[61],"III),":[62],"abstracts,":[63],"articles":[66],"concerning":[67],"combination":[68,128,233],"therapies":[69,131,158],"control":[72,259,278],"We":[76],"included":[77],"randomized":[78],"controlled":[79],"trials":[80,87],"(RCTs).":[81],"Results:":[82],"results":[84,114],"therapeutic":[86,268],"focused":[88],"on":[89,191],"actual":[91],"options":[92],"management":[95],"AMD":[98,228,279],"are":[99,216,253],"discussed.":[100],"Intravitreal":[101],"with":[103,124,129,159,166,209,265],"substances":[104],"targeting":[105],"all":[106],"isotypes":[107],"vascular":[109,321],"endothelial":[110,322],"growth":[111,323],"factor":[112,324],"(VEGF)":[113],"significant":[117],"increase":[118],"visual":[120,335],"acuity":[121],"patients":[123],"occlusive":[130,337],"like":[132],"verteporfin":[133,326],"photodynamic":[134,327],"therapy":[135,239,276,292,328],"(V-PDT)":[136],"potentially":[137],"offers":[138],"reduction":[140],"re-treatment":[142],"frequency":[143],"rate":[144],"long-term":[146],"maintenance":[147],"benefit":[150],"reached.":[151],"Despite":[152],"promise":[154],"from":[155],"combining":[156],"anti-VEGF":[157],"V-PDT,":[160],"other":[161,288],"combinations":[162],"improve":[164],"outcomes":[165],"V-PDT":[167],"deserve":[168],"attention.":[169],"Corticosteroids":[170],"demonstrated":[171],"an":[172,254],"antiangiogenic":[173],"effect":[174],"targeted":[176],"extravascular":[178],"components":[179,245],"CNV,":[181],"such":[182],"as":[183],"inflammatory":[184,340],"cells":[185],"fibrocytes.":[187],"Nevertheless,":[188],"study":[190],"application":[194],"corticosteroids":[196],"will":[197],"require":[198],"better":[200],"understanding":[201],"potential":[204],"complications.":[205],"Further":[206],"developments":[207],"interacting":[208],"various":[210],"steps":[211],"angiogenic":[214],"cascade":[215],"under":[217],"or":[219],"preclinical":[220],"evaluation":[221],"may":[223],"soon":[224],"become":[225],"available.":[226],"In":[227],"goal":[230],"regimen":[234],"address":[237,298],"toward":[240],"neovascular,":[241],"inflammatory,":[242],"proliferative":[244],"disease.":[248],"Conclusions:":[249],"Combined":[250],"strategies":[252],"obvious":[255],"step":[256],"providing":[257],"disease":[258,301],"when":[260],"it":[261],"not":[263],"achieved":[264],"single":[267,275],"approach.":[269],"One":[270],"risk":[271],"using":[273],"rebound":[282],"induced":[283],"by":[284],"compensatory":[285],"stimulation":[286],"pathogenetic":[289],"pathways.":[290],"Combination":[291],"logical":[295],"approach":[296],"mechanisms":[299],"progression":[302],"appear":[304],"be":[306],"self-sustaining":[307],"once":[308],"initiated.":[309],"Keywords:":[310],"Choroidal":[311],"neovascularisation":[312],"(CNV),":[313],"related":[315],"(AMD),":[318],"retinal":[319],"degeneration,":[320],"(VEGF),":[325],"(V-PDT),":[329],"anti-angiogenic":[330],"therapies,":[331,333,338],"isotypes,":[334],"acuity,":[336],"Corticosteroids,":[339],"cells,":[341],"fibrocytes,":[342],"Ranibizumab,":[343],"bevacizumab,":[344],"pegaptanib,":[345],"stroke,":[346],"myocardial":[347],"infarction,":[348],"MARINA,":[349],"ANCHOR,":[350],"immunosuppressants,":[351],"rapamycin,":[352],"hypoxia,":[353],"steroids,":[354],"attenuation":[355]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}